Compounds > epiberberine
Page last updated: 2024-09-04

epiberberine and puromycin

epiberberine has been researched along with puromycin in 1 studies

Compound Research Comparison

Studies
(epiberberine)		Trials
(epiberberine)		Recent Studies (post-2010)
(epiberberine)		Studies
(puromycin)		Trials
(puromycin)		Recent Studies (post-2010) (puromycin)
490375,8281311

Protein Interaction Comparison

ProteinTaxonomyepiberberine (IC50)puromycin (IC50)
30S ribosomal protein S6Escherichia coli K-120.9
30S ribosomal protein S7Escherichia coli K-120.9
50S ribosomal protein L15Escherichia coli K-120.9
50S ribosomal protein L10Escherichia coli K-120.9
50S ribosomal protein L11Escherichia coli K-120.9
50S ribosomal protein L7/L12Escherichia coli K-120.9
50S ribosomal protein L19Escherichia coli K-120.9
50S ribosomal protein L1Escherichia coli K-120.9
50S ribosomal protein L20Escherichia coli K-120.9
50S ribosomal protein L27Escherichia coli K-120.9
50S ribosomal protein L28Escherichia coli K-120.9
50S ribosomal protein L29Escherichia coli K-120.9
50S ribosomal protein L31Escherichia coli K-120.9
50S ribosomal protein L31 type BEscherichia coli K-120.9
50S ribosomal protein L32Escherichia coli K-120.9
50S ribosomal protein L33Escherichia coli K-120.9
50S ribosomal protein L34Escherichia coli K-120.9
50S ribosomal protein L35Escherichia coli K-120.9
50S ribosomal protein L36Escherichia coli K-120.9
30S ribosomal protein S10Escherichia coli K-120.9
30S ribosomal protein S11Escherichia coli K-120.9
30S ribosomal protein S12Escherichia coli K-120.9
30S ribosomal protein S13Escherichia coli K-120.9
30S ribosomal protein S16Escherichia coli K-120.9
30S ribosomal protein S18Escherichia coli K-120.9
30S ribosomal protein S19Escherichia coli K-120.9
30S ribosomal protein S20Escherichia coli K-120.9
30S ribosomal protein S2Escherichia coli K-120.9
30S ribosomal protein S3Escherichia coli K-120.9
30S ribosomal protein S4Escherichia coli K-120.9
30S ribosomal protein S5Escherichia coli K-120.9
30S ribosomal protein S8Escherichia coli K-120.9
30S ribosomal protein S9Escherichia coli K-120.9
50S ribosomal protein L13Escherichia coli K-120.9
50S ribosomal protein L14Escherichia coli K-120.9
50S ribosomal protein L16Escherichia coli K-120.9
50S ribosomal protein L23Escherichia coli K-120.9
30S ribosomal protein S15Escherichia coli K-120.9
50S ribosomal protein L17Escherichia coli K-120.9
50S ribosomal protein L21Escherichia coli K-120.9
50S ribosomal protein L30Escherichia coli K-120.9
50S ribosomal protein L6Escherichia coli K-120.9
30S ribosomal protein S14Escherichia coli K-120.9
30S ribosomal protein S17Escherichia coli K-120.9
30S ribosomal protein S1Escherichia coli K-120.9
50S ribosomal protein L18Escherichia coli K-120.9
Puromycin-sensitive aminopeptidaseHomo sapiens (human)6.075
50S ribosomal protein L2Escherichia coli K-120.9
50S ribosomal protein L3Escherichia coli K-120.9
50S ribosomal protein L24Escherichia coli K-120.9
50S ribosomal protein L4Escherichia coli K-120.9
50S ribosomal protein L22Escherichia coli K-120.9
50S ribosomal protein L5Escherichia coli K-120.9
30S ribosomal protein S21Escherichia coli K-120.9
50S ribosomal protein L25Escherichia coli K-120.9
50S ribosomal protein L36 2Escherichia coli K-120.9

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, SW; Bonamy, GM; Bopp, SE; Borboa, R; Bright, AT; Chatterjee, A; Che, J; Cohen, S; Dharia, NV; Diagana, TT; Fidock, DA; Froissard, P; Gagaring, K; Gettayacamin, M; Glynne, RJ; Gordon, P; Groessl, T; Kato, N; Kuhen, KL; Lee, MC; Mazier, D; McNamara, CW; Meister, S; Nagle, A; Nam, TG; Plouffe, DM; Richmond, W; Roland, J; Rottmann, M; Sattabongkot, J; Schultz, PG; Tuntland, T; Walker, JR; Winzeler, EA; Wu, T; Zhou, B; Zhou, Y1

Other Studies

1 other study(ies) available for epiberberine and puromycin

ArticleYear
Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery.
    Science (New York, N.Y.), 2011, Dec-09, Volume: 334, Issue:6061

    Topics: Animals; Antimalarials; Cell Line, Tumor; Drug Discovery; Drug Evaluation, Preclinical; Drug Resistance; Erythrocytes; Humans; Imidazoles; Liver; Malaria; Mice; Mice, Inbred BALB C; Molecular Structure; Piperazines; Plasmodium; Plasmodium berghei; Plasmodium falciparum; Plasmodium yoelii; Polymorphism, Single Nucleotide; Protozoan Proteins; Random Allocation; Small Molecule Libraries; Sporozoites

2011